BASAL CELL CARCINOMA:
DIAGNOSIS

If your healthcare provider suspects you have a basal cell carcinoma (BCC), you should be referred to a dermatologist. If your BCC is found early, it can usually be treated in the dermatologist’s office during a single visit.

 

Process for diagnosing BCC

  • Your dermatologist will take a medical history, addressing your sun-exposure history, any other relevant medical information, and your (as well as your family’s) history of any other skin cancers
  • The dermatologist may suggest a full head-to-toe skin examination to look for other problem areas. You can always ask your dermatologist to perform one if s/he doesn’t suggest it and you haven’t had one recently
  • The dermatologist will determine if you need a skin biopsy. S/he will numb the skin and take part or all of the spot. Biopsy is the only way to know whether the spot is actually cancer or not. That sample will be examined by a specialist who will look at the tissue under the microscope

 

Preparation for a Dermatology Appointment for a Suspected Skin Cancer

Your dermatologist will review the procedure with you, discuss the potential risks and benefits, answer your questions, and obtain your consent before doing the biopsy. In most cases, a biopsy can be completed in one visit. It can leave a little scar. Your dermatologist will provide you with specific details before the procedure. You may want to ask the following questions:

What is the next step?

How will I receive my results?

Can I please have a copy of the pathology report when it comes in?

Should I be getting regular skin checks?

What advice can you give me to better protect my skin from the sun?

What Will the Pathology Report Tell Me?

The specialist looking at your biopsy writes a report called a pathology report. The pathology report will contain some key information about the biopsy, such as the following:

  • Whether the specialist thinks it is cancer or not
  • If there is cancer, what type
  • The stage of the cancer based on the tumor characteristics
  • Whether the cancer has any “high-risk/aggressive” features